top of page
Fitness Woman Outdoors

Tesamorelin

Metabolic Health & Abdominal Fat Loss

Tesamorelin is a peptide that stimulates the pituitary gland to release growth hormone (GH), helping improve metabolism, body composition, and visceral fat reduction. It is a synthetic analog of Growth Hormone–Releasing Hormone (GHRH) and is one of the few peptides with strong clinical data specifically showing reductions in deep abdominal (visceral) fat.

Unlike general GH‑support peptides, Tesamorelin is particularly effective for:

  • Reducing visceral fat (the metabolically active fat around organs)

  • Improving metabolic health

  • Supporting lean muscle preservation

  • Enhancing energy and recovery

 

It works with your body’s natural hormone rhythms and does not replace growth hormone — it simply encourages your body to produce more of its own.

FAQs

What are the benefits of Tesamorelin?

  • Reduces visceral abdominal fat

  • Improves metabolic function and insulin sensitivity

  • Supports lean muscle mass

  • Enhances energy, stamina, and recovery

  • Improves sleep quality

  • Supports healthier lipid profiles

  • Helps counteract age‑related GH decline

  • May improve cognitive clarity and overall vitality

Am I a candidate?

  • Struggle with stubborn abdominal fat, especially visceral fat

  • Have metabolic challenges related to aging, stress, or hormones

  • Want to improve body composition without stimulants

  • Experience slow recovery or low energy

  • Are in perimenopause, menopause, or andropause

  • Want a more targeted approach than general GH‑support peptides

  • Are already working on nutrition and exercise but need metabolic support

Are there side effects of risks?

  • Mild injection‑site redness

  • Temporary bloating or water retention

  • Headache

  • Fatigue

  • Muscle tightness

Phone/Text: 214 888 6656

Fax: 469 319 2084

Hours: M-Th 8am-5pm, F 8am-2pm

550 South Watters Road

Ste 142

Allen, TX, USA

We'd love to hear from you

-Your Partner in Wellness

  • Instagram
  • Facebook
  • LinkedIn
bottom of page